lemme glp 1 results Inc., co-founded by Kourtney Kardashian, was accused in a new proposed class action for advertising its GLP1 supplement as working like FDA approved medications like semaglutide and Lemme GLP-1 Daily (NOT SPONSORED)

Market Opportunities Biosimilar Liraglutide Access Markets, Emerging Geography Expansion, and Precision Obesity Medicine Unlock Underserved GLP-1 Market Growth Segments Biosimilar liraglutide entry represents the first generic competition wave for the GLP-1 weight loss drug category, expanding access for the 480 million obesity patients in lower-middle income countries for whom USD 1,000-plus monthly branded drug pricing is permanently inaccessible

Not only did Houstinwho originally started on Ozempic before switching to Mounjaro due to terrible constipationstart to notice a difference in her appearance soon after starting the GLP-1, she has seen incredible health benefits

Reconstitute: Add 1.0 mL bacteriostatic water ~ 10.0 mg/mL concentration

This is why physician oversight is critical

Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives

There may be difficulties in having to refrigerate the injectable versions